<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Draft Guidance for Industry on Charging for Investigational Drugs Under an Investigational New Drug Application-Questions and Answers; Availability</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Draft Guidance for Industry on Charging for Investigational Drugs Under an Investigational New Drug Application-Questions and Answers; Availability</h1>
    <p class="timestamp">Published: 2013-05-09 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Food and Drug Administration (FDA) is announcing the availability of a draft guidance for industry entitled "Charging for Investigational Drugs Under an IND--Qs & As." This guidance is intended to provide information for industry, researchers, and physicians on how FDA is implementing its regulation on charging for an investigational drug under an investigational new drug (IND) application. FDA has received a number of questions about how it is implementing the charging regulation. Therefore...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Proposed Rule</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2013-11006</p>
    <p><strong>Publication Date:</strong> 2013-05-09</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2013/05/09/2013-11006/draft-guidance-for-industry-on-charging-for-investigational-drugs-under-an-investigational-new-drug">https://www.federalregister.gov/documents/2013/05/09/2013-11006/draft-guidance-for-industry-on-charging-for-investigational-drugs-under-an-investigational-new-drug</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2013-11006</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
